EUROPEAN RADIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2128662, encodeId=c23c21286620b, content=偏重的研究方向：MRI功能成像;MR 经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24b65460709, createdName=ms1000000394173917, createdTime=Thu Apr 27 14:22:56 CST 2023, time=2023-04-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2122048, encodeId=773621220486d, content=偏重的研究方向：MR 经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfa32137662, createdName=1861fe3195m, createdTime=Mon Mar 27 12:45:34 CST 2023, time=2023-03-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116364, encodeId=8b5b211636418, content=审稿速度:1.0 经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投 不会再投的，投低分都不投了，“原是我不配”.jpg, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d75445531, createdName=ms7000001149298729, createdTime=Sat Feb 25 00:03:20 CST 2023, time=2023-02-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126374, encodeId=69fc21263e4ee, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：CT;Radiology 经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=北境之王, createdTime=Sun Apr 16 22:02:05 CST 2023, time=2023-04-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2120922, encodeId=557e2120922a2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f428599118, createdName=ms6000001513629735, createdTime=Tue Mar 21 23:19:32 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122985, encodeId=7958212298555, content=请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e266155917, createdName=ms5000001433953724, createdTime=Fri Mar 31 16:49:09 CST 2023, time=2023-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121369, encodeId=02682121369f1, content=拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b3f8601820, createdName=ms2000000237037861, createdTime=Thu Mar 23 16:44:32 CST 2023, time=2023-03-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108747, encodeId=727f2108e475d, content=偏重的研究方向：MR 经验分享：请问reject and resubmit，有必要重投吗？有没机会？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/1d968e190da745b6a5f02a8d544378c9/436c74b036e14af1bfd23c39b1d513b2.jpg, createdBy=0d6f4673141, createdName=月光也会陪着我, createdTime=Wed Jan 04 11:11:56 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116933, encodeId=36d0211693391, content=供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9206540629, createdName=ms9000001215512485, createdTime=Tue Feb 28 18:41:15 CST 2023, time=2023-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116271, encodeId=20d821162e128, content=现在好慢啊，都两个多月了。还没有进入审稿流程, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=621b52482, createdName=shuangyu0307, createdTime=Fri Feb 24 14:03:14 CST 2023, time=2023-02-24, status=1, ipAttribution=河南省)]

2023-04-27 ms1000000394173917 来自云南省

偏重的研究方向：MRI功能成像;MR
经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了

57 0

[GetPortalCommentsPageByObjectIdResponse(id=2128662, encodeId=c23c21286620b, content=偏重的研究方向：MRI功能成像;MR 经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24b65460709, createdName=ms1000000394173917, createdTime=Thu Apr 27 14:22:56 CST 2023, time=2023-04-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2122048, encodeId=773621220486d, content=偏重的研究方向：MR 经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfa32137662, createdName=1861fe3195m, createdTime=Mon Mar 27 12:45:34 CST 2023, time=2023-03-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116364, encodeId=8b5b211636418, content=审稿速度:1.0 经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投 不会再投的，投低分都不投了，“原是我不配”.jpg, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d75445531, createdName=ms7000001149298729, createdTime=Sat Feb 25 00:03:20 CST 2023, time=2023-02-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126374, encodeId=69fc21263e4ee, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：CT;Radiology 经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=北境之王, createdTime=Sun Apr 16 22:02:05 CST 2023, time=2023-04-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2120922, encodeId=557e2120922a2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f428599118, createdName=ms6000001513629735, createdTime=Tue Mar 21 23:19:32 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122985, encodeId=7958212298555, content=请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e266155917, createdName=ms5000001433953724, createdTime=Fri Mar 31 16:49:09 CST 2023, time=2023-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121369, encodeId=02682121369f1, content=拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b3f8601820, createdName=ms2000000237037861, createdTime=Thu Mar 23 16:44:32 CST 2023, time=2023-03-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108747, encodeId=727f2108e475d, content=偏重的研究方向：MR 经验分享：请问reject and resubmit，有必要重投吗？有没机会？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/1d968e190da745b6a5f02a8d544378c9/436c74b036e14af1bfd23c39b1d513b2.jpg, createdBy=0d6f4673141, createdName=月光也会陪着我, createdTime=Wed Jan 04 11:11:56 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116933, encodeId=36d0211693391, content=供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9206540629, createdName=ms9000001215512485, createdTime=Tue Feb 28 18:41:15 CST 2023, time=2023-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116271, encodeId=20d821162e128, content=现在好慢啊，都两个多月了。还没有进入审稿流程, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=621b52482, createdName=shuangyu0307, createdTime=Fri Feb 24 14:03:14 CST 2023, time=2023-02-24, status=1, ipAttribution=河南省)]

2023-03-27 1861fe3195m 来自上海

偏重的研究方向：MR
经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。

91 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128662, encodeId=c23c21286620b, content=偏重的研究方向：MRI功能成像;MR 经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24b65460709, createdName=ms1000000394173917, createdTime=Thu Apr 27 14:22:56 CST 2023, time=2023-04-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2122048, encodeId=773621220486d, content=偏重的研究方向：MR 经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfa32137662, createdName=1861fe3195m, createdTime=Mon Mar 27 12:45:34 CST 2023, time=2023-03-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116364, encodeId=8b5b211636418, content=审稿速度:1.0 经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投 不会再投的，投低分都不投了，“原是我不配”.jpg, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d75445531, createdName=ms7000001149298729, createdTime=Sat Feb 25 00:03:20 CST 2023, time=2023-02-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126374, encodeId=69fc21263e4ee, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：CT;Radiology 经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=北境之王, createdTime=Sun Apr 16 22:02:05 CST 2023, time=2023-04-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2120922, encodeId=557e2120922a2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f428599118, createdName=ms6000001513629735, createdTime=Tue Mar 21 23:19:32 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122985, encodeId=7958212298555, content=请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e266155917, createdName=ms5000001433953724, createdTime=Fri Mar 31 16:49:09 CST 2023, time=2023-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121369, encodeId=02682121369f1, content=拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b3f8601820, createdName=ms2000000237037861, createdTime=Thu Mar 23 16:44:32 CST 2023, time=2023-03-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108747, encodeId=727f2108e475d, content=偏重的研究方向：MR 经验分享：请问reject and resubmit，有必要重投吗？有没机会？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/1d968e190da745b6a5f02a8d544378c9/436c74b036e14af1bfd23c39b1d513b2.jpg, createdBy=0d6f4673141, createdName=月光也会陪着我, createdTime=Wed Jan 04 11:11:56 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116933, encodeId=36d0211693391, content=供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9206540629, createdName=ms9000001215512485, createdTime=Tue Feb 28 18:41:15 CST 2023, time=2023-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116271, encodeId=20d821162e128, content=现在好慢啊，都两个多月了。还没有进入审稿流程, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=621b52482, createdName=shuangyu0307, createdTime=Fri Feb 24 14:03:14 CST 2023, time=2023-02-24, status=1, ipAttribution=河南省)]

2023-02-25 ms7000001149298729 来自重庆

审稿速度:1.0
经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投
不会再投的，投低分都不投了，“原是我不配”.jpg

107 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128662, encodeId=c23c21286620b, content=偏重的研究方向：MRI功能成像;MR 经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24b65460709, createdName=ms1000000394173917, createdTime=Thu Apr 27 14:22:56 CST 2023, time=2023-04-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2122048, encodeId=773621220486d, content=偏重的研究方向：MR 经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfa32137662, createdName=1861fe3195m, createdTime=Mon Mar 27 12:45:34 CST 2023, time=2023-03-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116364, encodeId=8b5b211636418, content=审稿速度:1.0 经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投 不会再投的，投低分都不投了，“原是我不配”.jpg, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d75445531, createdName=ms7000001149298729, createdTime=Sat Feb 25 00:03:20 CST 2023, time=2023-02-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126374, encodeId=69fc21263e4ee, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：CT;Radiology 经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=北境之王, createdTime=Sun Apr 16 22:02:05 CST 2023, time=2023-04-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2120922, encodeId=557e2120922a2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f428599118, createdName=ms6000001513629735, createdTime=Tue Mar 21 23:19:32 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122985, encodeId=7958212298555, content=请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e266155917, createdName=ms5000001433953724, createdTime=Fri Mar 31 16:49:09 CST 2023, time=2023-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121369, encodeId=02682121369f1, content=拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b3f8601820, createdName=ms2000000237037861, createdTime=Thu Mar 23 16:44:32 CST 2023, time=2023-03-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108747, encodeId=727f2108e475d, content=偏重的研究方向：MR 经验分享：请问reject and resubmit，有必要重投吗？有没机会？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/1d968e190da745b6a5f02a8d544378c9/436c74b036e14af1bfd23c39b1d513b2.jpg, createdBy=0d6f4673141, createdName=月光也会陪着我, createdTime=Wed Jan 04 11:11:56 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116933, encodeId=36d0211693391, content=供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9206540629, createdName=ms9000001215512485, createdTime=Tue Feb 28 18:41:15 CST 2023, time=2023-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116271, encodeId=20d821162e128, content=现在好慢啊，都两个多月了。还没有进入审稿流程, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=621b52482, createdName=shuangyu0307, createdTime=Fri Feb 24 14:03:14 CST 2023, time=2023-02-24, status=1, ipAttribution=河南省)]

2023-04-16 北境之王来自辽宁省

审稿速度:6.0 | 投稿命中率:25.0
偏重的研究方向：CT;Radiology
经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author

60 0

[GetPortalCommentsPageByObjectIdResponse(id=2128662, encodeId=c23c21286620b, content=偏重的研究方向：MRI功能成像;MR 经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24b65460709, createdName=ms1000000394173917, createdTime=Thu Apr 27 14:22:56 CST 2023, time=2023-04-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2122048, encodeId=773621220486d, content=偏重的研究方向：MR 经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfa32137662, createdName=1861fe3195m, createdTime=Mon Mar 27 12:45:34 CST 2023, time=2023-03-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116364, encodeId=8b5b211636418, content=审稿速度:1.0 经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投 不会再投的，投低分都不投了，“原是我不配”.jpg, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d75445531, createdName=ms7000001149298729, createdTime=Sat Feb 25 00:03:20 CST 2023, time=2023-02-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126374, encodeId=69fc21263e4ee, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：CT;Radiology 经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=北境之王, createdTime=Sun Apr 16 22:02:05 CST 2023, time=2023-04-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2120922, encodeId=557e2120922a2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f428599118, createdName=ms6000001513629735, createdTime=Tue Mar 21 23:19:32 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122985, encodeId=7958212298555, content=请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e266155917, createdName=ms5000001433953724, createdTime=Fri Mar 31 16:49:09 CST 2023, time=2023-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121369, encodeId=02682121369f1, content=拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b3f8601820, createdName=ms2000000237037861, createdTime=Thu Mar 23 16:44:32 CST 2023, time=2023-03-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108747, encodeId=727f2108e475d, content=偏重的研究方向：MR 经验分享：请问reject and resubmit，有必要重投吗？有没机会？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/1d968e190da745b6a5f02a8d544378c9/436c74b036e14af1bfd23c39b1d513b2.jpg, createdBy=0d6f4673141, createdName=月光也会陪着我, createdTime=Wed Jan 04 11:11:56 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116933, encodeId=36d0211693391, content=供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9206540629, createdName=ms9000001215512485, createdTime=Tue Feb 28 18:41:15 CST 2023, time=2023-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116271, encodeId=20d821162e128, content=现在好慢啊，都两个多月了。还没有进入审稿流程, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=621b52482, createdName=shuangyu0307, createdTime=Fri Feb 24 14:03:14 CST 2023, time=2023-02-24, status=1, ipAttribution=河南省)]

2023-03-21 ms6000001513629735 来自广东省

审稿速度:2.0 | 投稿命中率:25.0
经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？

68 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128662, encodeId=c23c21286620b, content=偏重的研究方向：MRI功能成像;MR 经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24b65460709, createdName=ms1000000394173917, createdTime=Thu Apr 27 14:22:56 CST 2023, time=2023-04-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2122048, encodeId=773621220486d, content=偏重的研究方向：MR 经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfa32137662, createdName=1861fe3195m, createdTime=Mon Mar 27 12:45:34 CST 2023, time=2023-03-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116364, encodeId=8b5b211636418, content=审稿速度:1.0 经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投 不会再投的，投低分都不投了，“原是我不配”.jpg, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d75445531, createdName=ms7000001149298729, createdTime=Sat Feb 25 00:03:20 CST 2023, time=2023-02-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126374, encodeId=69fc21263e4ee, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：CT;Radiology 经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=北境之王, createdTime=Sun Apr 16 22:02:05 CST 2023, time=2023-04-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2120922, encodeId=557e2120922a2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f428599118, createdName=ms6000001513629735, createdTime=Tue Mar 21 23:19:32 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122985, encodeId=7958212298555, content=请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e266155917, createdName=ms5000001433953724, createdTime=Fri Mar 31 16:49:09 CST 2023, time=2023-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121369, encodeId=02682121369f1, content=拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b3f8601820, createdName=ms2000000237037861, createdTime=Thu Mar 23 16:44:32 CST 2023, time=2023-03-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108747, encodeId=727f2108e475d, content=偏重的研究方向：MR 经验分享：请问reject and resubmit，有必要重投吗？有没机会？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/1d968e190da745b6a5f02a8d544378c9/436c74b036e14af1bfd23c39b1d513b2.jpg, createdBy=0d6f4673141, createdName=月光也会陪着我, createdTime=Wed Jan 04 11:11:56 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116933, encodeId=36d0211693391, content=供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9206540629, createdName=ms9000001215512485, createdTime=Tue Feb 28 18:41:15 CST 2023, time=2023-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116271, encodeId=20d821162e128, content=现在好慢啊，都两个多月了。还没有进入审稿流程, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=621b52482, createdName=shuangyu0307, createdTime=Fri Feb 24 14:03:14 CST 2023, time=2023-02-24, status=1, ipAttribution=河南省)]

2023-03-31 ms5000001433953724

请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板

1 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128662, encodeId=c23c21286620b, content=偏重的研究方向：MRI功能成像;MR 经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24b65460709, createdName=ms1000000394173917, createdTime=Thu Apr 27 14:22:56 CST 2023, time=2023-04-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2122048, encodeId=773621220486d, content=偏重的研究方向：MR 经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfa32137662, createdName=1861fe3195m, createdTime=Mon Mar 27 12:45:34 CST 2023, time=2023-03-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116364, encodeId=8b5b211636418, content=审稿速度:1.0 经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投 不会再投的，投低分都不投了，“原是我不配”.jpg, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d75445531, createdName=ms7000001149298729, createdTime=Sat Feb 25 00:03:20 CST 2023, time=2023-02-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126374, encodeId=69fc21263e4ee, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：CT;Radiology 经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=北境之王, createdTime=Sun Apr 16 22:02:05 CST 2023, time=2023-04-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2120922, encodeId=557e2120922a2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f428599118, createdName=ms6000001513629735, createdTime=Tue Mar 21 23:19:32 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122985, encodeId=7958212298555, content=请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e266155917, createdName=ms5000001433953724, createdTime=Fri Mar 31 16:49:09 CST 2023, time=2023-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121369, encodeId=02682121369f1, content=拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b3f8601820, createdName=ms2000000237037861, createdTime=Thu Mar 23 16:44:32 CST 2023, time=2023-03-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108747, encodeId=727f2108e475d, content=偏重的研究方向：MR 经验分享：请问reject and resubmit，有必要重投吗？有没机会？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/1d968e190da745b6a5f02a8d544378c9/436c74b036e14af1bfd23c39b1d513b2.jpg, createdBy=0d6f4673141, createdName=月光也会陪着我, createdTime=Wed Jan 04 11:11:56 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116933, encodeId=36d0211693391, content=供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9206540629, createdName=ms9000001215512485, createdTime=Tue Feb 28 18:41:15 CST 2023, time=2023-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116271, encodeId=20d821162e128, content=现在好慢啊，都两个多月了。还没有进入审稿流程, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=621b52482, createdName=shuangyu0307, createdTime=Fri Feb 24 14:03:14 CST 2023, time=2023-02-24, status=1, ipAttribution=河南省)]

2023-03-23 ms2000000237037861 来自河北省

拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊

73 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128662, encodeId=c23c21286620b, content=偏重的研究方向：MRI功能成像;MR 经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24b65460709, createdName=ms1000000394173917, createdTime=Thu Apr 27 14:22:56 CST 2023, time=2023-04-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2122048, encodeId=773621220486d, content=偏重的研究方向：MR 经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfa32137662, createdName=1861fe3195m, createdTime=Mon Mar 27 12:45:34 CST 2023, time=2023-03-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116364, encodeId=8b5b211636418, content=审稿速度:1.0 经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投 不会再投的，投低分都不投了，“原是我不配”.jpg, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d75445531, createdName=ms7000001149298729, createdTime=Sat Feb 25 00:03:20 CST 2023, time=2023-02-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126374, encodeId=69fc21263e4ee, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：CT;Radiology 经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=北境之王, createdTime=Sun Apr 16 22:02:05 CST 2023, time=2023-04-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2120922, encodeId=557e2120922a2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f428599118, createdName=ms6000001513629735, createdTime=Tue Mar 21 23:19:32 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122985, encodeId=7958212298555, content=请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e266155917, createdName=ms5000001433953724, createdTime=Fri Mar 31 16:49:09 CST 2023, time=2023-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121369, encodeId=02682121369f1, content=拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b3f8601820, createdName=ms2000000237037861, createdTime=Thu Mar 23 16:44:32 CST 2023, time=2023-03-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108747, encodeId=727f2108e475d, content=偏重的研究方向：MR 经验分享：请问reject and resubmit，有必要重投吗？有没机会？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/1d968e190da745b6a5f02a8d544378c9/436c74b036e14af1bfd23c39b1d513b2.jpg, createdBy=0d6f4673141, createdName=月光也会陪着我, createdTime=Wed Jan 04 11:11:56 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116933, encodeId=36d0211693391, content=供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9206540629, createdName=ms9000001215512485, createdTime=Tue Feb 28 18:41:15 CST 2023, time=2023-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116271, encodeId=20d821162e128, content=现在好慢啊，都两个多月了。还没有进入审稿流程, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=621b52482, createdName=shuangyu0307, createdTime=Fri Feb 24 14:03:14 CST 2023, time=2023-02-24, status=1, ipAttribution=河南省)]

2023-01-04 月光也会陪着我

偏重的研究方向：MR
经验分享：请问reject and resubmit，有必要重投吗？有没机会？

147 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2128662, encodeId=c23c21286620b, content=偏重的研究方向：MRI功能成像;MR 经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24b65460709, createdName=ms1000000394173917, createdTime=Thu Apr 27 14:22:56 CST 2023, time=2023-04-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2122048, encodeId=773621220486d, content=偏重的研究方向：MR 经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfa32137662, createdName=1861fe3195m, createdTime=Mon Mar 27 12:45:34 CST 2023, time=2023-03-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116364, encodeId=8b5b211636418, content=审稿速度:1.0 经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投 不会再投的，投低分都不投了，“原是我不配”.jpg, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d75445531, createdName=ms7000001149298729, createdTime=Sat Feb 25 00:03:20 CST 2023, time=2023-02-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126374, encodeId=69fc21263e4ee, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：CT;Radiology 经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=北境之王, createdTime=Sun Apr 16 22:02:05 CST 2023, time=2023-04-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2120922, encodeId=557e2120922a2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f428599118, createdName=ms6000001513629735, createdTime=Tue Mar 21 23:19:32 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122985, encodeId=7958212298555, content=请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e266155917, createdName=ms5000001433953724, createdTime=Fri Mar 31 16:49:09 CST 2023, time=2023-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121369, encodeId=02682121369f1, content=拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b3f8601820, createdName=ms2000000237037861, createdTime=Thu Mar 23 16:44:32 CST 2023, time=2023-03-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108747, encodeId=727f2108e475d, content=偏重的研究方向：MR 经验分享：请问reject and resubmit，有必要重投吗？有没机会？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/1d968e190da745b6a5f02a8d544378c9/436c74b036e14af1bfd23c39b1d513b2.jpg, createdBy=0d6f4673141, createdName=月光也会陪着我, createdTime=Wed Jan 04 11:11:56 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116933, encodeId=36d0211693391, content=供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9206540629, createdName=ms9000001215512485, createdTime=Tue Feb 28 18:41:15 CST 2023, time=2023-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116271, encodeId=20d821162e128, content=现在好慢啊，都两个多月了。还没有进入审稿流程, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=621b52482, createdName=shuangyu0307, createdTime=Fri Feb 24 14:03:14 CST 2023, time=2023-02-24, status=1, ipAttribution=河南省)]

2023-02-28 ms9000001215512485 来自上海

供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept

86 0

[GetPortalCommentsPageByObjectIdResponse(id=2128662, encodeId=c23c21286620b, content=偏重的研究方向：MRI功能成像;MR 经验分享：投的基础研究文章杂质喜欢临床外审三个月就结束了不知道是不是被拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=24b65460709, createdName=ms1000000394173917, createdTime=Thu Apr 27 14:22:56 CST 2023, time=2023-04-27, status=1, ipAttribution=云南省), GetPortalCommentsPageByObjectIdResponse(id=2122048, encodeId=773621220486d, content=偏重的研究方向：MR 经验分享：2022年 1.24 new submission 2.7 editor assigned 2.22 reviewers assigned 2.27 under review 3.23 reviews completed 4.6 reject and resubmit 10.16 resubmit 12.23 major revision 2023年 1.22 major revision 3.3 minor revision 3.26 accept 4-10月把文章大修了一遍，改投悲剧了又投回Er，供大家参考。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dfa32137662, createdName=1861fe3195m, createdTime=Mon Mar 27 12:45:34 CST 2023, time=2023-03-27, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116364, encodeId=8b5b211636418, content=审稿速度:1.0 经验分享：第一个审稿人说可以考虑加图，没得其他意见；第二个审稿人说需要外部验证，讨论需要再一段深入讨论；第三个审稿人让方法补充细节，其余都ok。然后编辑：婉拒了哈，欢迎认真修改了再投 不会再投的，投低分都不投了，“原是我不配”.jpg, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=107, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=50d75445531, createdName=ms7000001149298729, createdTime=Sat Feb 25 00:03:20 CST 2023, time=2023-02-25, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2126374, encodeId=69fc21263e4ee, content=审稿速度:6.0 | 投稿命中率:25.0 偏重的研究方向：CT;Radiology 经验分享：一审小修，顺利接收，整体来说审稿周期还是有点长，5个多月。祝大家顺利啊！ 14 Apr 2023 Editor Decision - Accept 18 Mar 2023 AU - Author Approves Changes 18 Mar 2023 AU - Revised PDF Built by Author 16 Mar 2023 AU - Return Submission after Technical Check 15 Mar 2023 Ad Hoc from Author to Editorial Office 15 Mar 2023 AU - Author Revision 15 Mar 2023 AU - Revised PDF Built by Author 06 Feb 2023 Editor Decision - Minor Revision 08 Dec 2022 AU - Author Approves Changes 08 Dec 2022 AU - Original PDF Built by Author 05 Dec 2022 AU - Return Submission after Technical Check 14 Nov 2022 AU - Author Submission 14 Nov 2022 AU - Original PDF Built by Author, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221124/c764517f78cc48198d8dbccc27d7d534/b6cbac9da7fd4845ace81efbf731b946.jpg, createdBy=57765338383, createdName=北境之王, createdTime=Sun Apr 16 22:02:05 CST 2023, time=2023-04-16, status=1, ipAttribution=辽宁省), GetPortalCommentsPageByObjectIdResponse(id=2120922, encodeId=557e2120922a2, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：请问大家review completed之后作者稿件里面没有了Submissions Being Processed，点不开提交过的稿件信息，这是什么情况？是被拒了吗？被拒了应该也会有信息显示吧？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=68, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1f428599118, createdName=ms6000001513629735, createdTime=Tue Mar 21 23:19:32 CST 2023, time=2023-03-21, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2122985, encodeId=7958212298555, content=请问各位大佬，ER没有写作模板吗？从官网上没找到word或者latex的模板, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e266155917, createdName=ms5000001433953724, createdTime=Fri Mar 31 16:49:09 CST 2023, time=2023-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2121369, encodeId=02682121369f1, content=拒稿重投提交以后，然后我觉得算是小修吧，一个专家没有意见了，另外一个专家提了一个意见，这样的会不会返修回去以后，会不会被拒稿啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=73, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b3f8601820, createdName=ms2000000237037861, createdTime=Thu Mar 23 16:44:32 CST 2023, time=2023-03-23, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2108747, encodeId=727f2108e475d, content=偏重的研究方向：MR 经验分享：请问reject and resubmit，有必要重投吗？有没机会？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=147, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210918/1d968e190da745b6a5f02a8d544378c9/436c74b036e14af1bfd23c39b1d513b2.jpg, createdBy=0d6f4673141, createdName=月光也会陪着我, createdTime=Wed Jan 04 11:11:56 CST 2023, time=2023-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2116933, encodeId=36d0211693391, content=供大家参考，历经小半年：10.8 Submission，12.3 Under review，1.7 Major revision，1.31 Resubmit，2.27 Accept, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d9206540629, createdName=ms9000001215512485, createdTime=Tue Feb 28 18:41:15 CST 2023, time=2023-02-28, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2116271, encodeId=20d821162e128, content=现在好慢啊，都两个多月了。还没有进入审稿流程, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=621b52482, createdName=shuangyu0307, createdTime=Fri Feb 24 14:03:14 CST 2023, time=2023-02-24, status=1, ipAttribution=河南省)]

2023-02-24 shuangyu0307 来自河南省

现在好慢啊，都两个多月了。还没有进入审稿流程

53 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务